Kintara Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

TuHURA Biosciences

11/05/2023 15:12

* Kintara Therapeutics Inc  KTRA.OQ  reported a quarterly
adjusted
loss of $1.94​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 19 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Kintara Therapeutics Inc's reported EPS for the quarter
was a
loss of $1.94​.
    * The mean earnings estimate of analysts had risen by
about 89.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Kintara Therapeutics Inc shares had fallen by 3.4% this
quarter and lost 50.5% so far this year.
    * The company reported a quarterly loss of $3.27 million.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 02:12 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.19          -1.94          Missed
 Dec. 31 2022      -3.16          -2.10          Beat
 Sep. 30 2022      0.00           -3.50          Missed
 Jun. 30 2022      -1.50          -5.50          Missed